This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,453 Years Active: 2003
Title: Keith Elkon: Innovator in Immune Response Inhibition
Introduction
Keith Elkon is a notable inventor based in Larchmont, NY (US). He has made significant contributions to the field of immunology, particularly in the development of methods to inhibit immune responses to recombinant vectors. His work is crucial for advancing therapeutic applications involving viral vectors.
Latest Patents
Keith Elkon holds 1 patent for a method of inhibiting an immune response to a recombinant vector. This invention provides a method that involves contacting a cell with a recombinant vector, specifically an adenoviral vector, along with a means of inhibiting the immune response. The patent outlines the use of various fusion proteins and genes to achieve this inhibition, which is essential for improving the efficacy of gene therapy.
Career Highlights
Throughout his career, Keith has focused on innovative approaches to immunology and gene therapy. His research has contributed to a better understanding of how to manipulate immune responses, which is vital for the success of various therapeutic interventions.
Collaborations
Keith has collaborated with Erik S Falck-Pedersen, a fellow researcher in the field. Their partnership has likely enhanced the development and application of their innovative methods.
Conclusion
Keith Elkon's work in inhibiting immune responses to recombinant vectors represents a significant advancement in immunology. His contributions are paving the way for more effective gene therapies and treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile